<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39446726</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Substance abuse among new patients attending main government hospitals in Malaysia from 2018-2021: A comparison between before and during COVID-19 pandemic.</ArticleTitle><Pagination><StartPage>e0309422</StartPage><MedlinePgn>e0309422</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0309422</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0309422</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Substance abuse admission to health facilities following the pandemic is often met with challenges. COVID-19 is causing an insurmountable psychosocial impact on the whole of mankind. Marginalized communities, particularly those with substance use disorders (SUDs), are also likely to suffer from greater psychosocial burden.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study sought to evaluate substance abuse trends before and during the pandemic.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A cross-sectional study was conducted among patients attending selected government hospitals in Malaysia. Data from the year 2018 to 2021 was utilized.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 9,606 patients consisting of 7881 males and 1725 females were identified. Most of the patients involved with substance abuse from 2018 to 2021 were males, aged between 26 and 44 years old, Malays, high school students, singles, workers of private sectors and those residing in urban areas. The most abused substances over the four years were tobacco (61.8%), followed by amphetamine-type stimulants (ATS) (43.1%), alcohol (39.7%), cannabis (17.2%), opioids (13.0%), and kratom (8.8%). Those who worked in the private sector and were self-employed or unemployed were more associated with substance abuse during the pandemic compared to those who worked in the government sector. Those with a history of psychiatric illness were more associated with abuse of substances during the pandemic than those without the history (adjusted OR: 1.18, 95% CI 1.09-1.29, p &lt;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Targeted exploration of factors affecting substance abuse in Malaysia is essential. The results of this study assist in identifying variations in substance abuse treatment characteristics for those admitted to treatment in Malaysia.</AbstractText><CopyrightInformation>Copyright: © 2024 Muhamad et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Muhamad</LastName><ForeName>Nor Asiah</ForeName><Initials>NA</Initials><Identifier Source="ORCID">0000-0002-7772-2103</Identifier><AffiliationInfo><Affiliation>Sector for Evidence-Based Healthcare, National Institutes of Health, Ministry of Health, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chemi</LastName><ForeName>Norliza</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Kajang Hospital, Ministry of Health, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma'amor</LastName><ForeName>Nur Hasnah</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Sector for Evidence-Based Healthcare, National Institutes of Health, Ministry of Health, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosli</LastName><ForeName>Izzah Athirah</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Sector for Evidence-Based Healthcare, National Institutes of Health, Ministry of Health, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leman</LastName><ForeName>Fatin Norhasny</ForeName><Initials>FN</Initials><AffiliationInfo><Affiliation>Sector for Evidence-Based Healthcare, National Institutes of Health, Ministry of Health, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohamad Isa</LastName><ForeName>Mohd Fadzli</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Kuala Lumpur Hospital, Ministry of Health, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johari</LastName><ForeName>Mohammad Zabri</ForeName><Initials>MZ</Initials><Identifier Source="ORCID">0000-0002-8017-622X</Identifier><AffiliationInfo><Affiliation>Institute for Behavioural Health Research, National Institutes of Health, Ministry of Health, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdullah</LastName><ForeName>Norni</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Tengku Ampuan Rahimah Hospital, Ministry of Health, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Nor Ashikin</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>National Centre of Excellence for Mental Health, Cyberjaya, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Huan-Keat</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Clinical Research Centre, Sultanah Bahiyah Hospital, Ministry of Health, Kedah, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu Hassan</LastName><ForeName>Muhammad Radzi</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Clinical Research Centre, Sultanah Bahiyah Hospital, Ministry of Health, Kedah, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>My Substance Abuse Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008296" MajorTopicYN="N" Type="Geographic">Malaysia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019966" MajorTopicYN="Y">Substance-Related Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006779" MajorTopicYN="N">Hospitals, Public</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>7</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39446726</ArticleId><ArticleId IdType="pmc">PMC11500913</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0309422</ArticleId><ArticleId IdType="pii">PONE-D-24-00826</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al.. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet [Internet]. 2018;392(10159):1789–858. Available from: https://www.sciencedirect.com/science/article/pii/S0140673618322797
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6227754</ArticleId><ArticleId IdType="pubmed">30496104</ArticleId></ArticleIdList></Reference><Reference><Citation>Degenhardt L, Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, Hall WD, et al.. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet (London, England). 2013. Nov;382(9904):1564–74. DOI: 10.1016/S0140-6736(13)61530-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61530-5</ArticleId><ArticleId IdType="pubmed">23993281</ArticleId></ArticleIdList></Reference><Reference><Citation>Ndetei DM, Khasakhala LI, Ongecha-Owuor FA, Kuria MW, Mutiso V, Kokonya DA. Prevalence of Substance Abuse Among Patients in General Medical Facilities in Kenya. Subst Abus [Internet]. 2009. Apr 21;30(2):182–90. Available from: 10.1080/08897070902802125</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08897070902802125</ArticleId><ArticleId IdType="pubmed">19347756</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaman Muhammad, Razzaq S, Hassan R, Qureshi J, Ijaz H, et al.. Drug abuse among the students. Pakistan J Pharm Res 1. 2015;1(1):41–7.</Citation></Reference><Reference><Citation>Cummings JR, Wen H, Ko M, Druss BG. Race/Ethnicity and Geographic Access to Medicaid Substance Use Disorder Treatment Facilities in the United States. JAMA Psychiatry [Internet]. 2014. Feb 1;71(2):190–6. Available from: 10.1001/jamapsychiatry.2013.3575</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2013.3575</ArticleId><ArticleId IdType="pmc">PMC4039494</ArticleId><ArticleId IdType="pubmed">24369387</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. 2013.</Citation></Reference><Reference><Citation>O’Brien C. Addiction and dependence in DSM-V. Addiction. 2011. May;106(5):866–7. doi: 10.1111/j.1360-0443.2010.03144.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1360-0443.2010.03144.x</ArticleId><ArticleId IdType="pmc">PMC3812919</ArticleId><ArticleId IdType="pubmed">21477226</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasin DS, O’Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, et al.. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013. Aug;170(8):834–51. doi: 10.1176/appi.ajp.2013.12060782</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2013.12060782</ArticleId><ArticleId IdType="pmc">PMC3767415</ArticleId><ArticleId IdType="pubmed">23903334</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong S, Yu R, Fazel S. Drug Use Disorders and Violence: Associations With Individual Drug Categories. Epidemiol Rev [Internet]. 2020. Jan 31;42(1):103–16. Available from: 10.1093/epirev/mxaa006</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/epirev/mxaa006</ArticleId><ArticleId IdType="pmc">PMC7879597</ArticleId><ArticleId IdType="pubmed">33005950</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitesell M, Bachand A, Peel J, Brown M. Familial, social, and individual factors contributing to risk for adolescent substance use. J Addict. 2013;2013:579310. doi: 10.1155/2013/579310</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/579310</ArticleId><ArticleId IdType="pmc">PMC4008086</ArticleId><ArticleId IdType="pubmed">24826363</ArticleId></ArticleIdList></Reference><Reference><Citation>World Drug Report [Internet]. United Nations publication, Sales No. E.21.XI.8. 2021. Available from: https://www.unodc.org/res/wdr2021/field/WDR21_Booklet_1.pdf</Citation></Reference><Reference><Citation>Samsudi SM. Dealing with Drug Abuse during COVID-19 [Internet]. 2021. Available from: https://www.ikim.gov.my/new-wp/index.php/2021/12/02/dealing-with-drug-abuse-during-covid-19/</Citation></Reference><Reference><Citation>Dubey MJ, Ghosh R, Chatterjee S, Biswas P, Chatterjee S, Dubey S. COVID-19 and addiction. Diabetes Metab Syndr Clin Res Rev [Internet]. 2020;14(5):817–23. Available from: https://www.sciencedirect.com/science/article/pii/S1871402120301776</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7282772</ArticleId><ArticleId IdType="pubmed">32540735</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartwell KJ, Tolliver BK, Brady KT. Biologic Commonalities between Mental Illness and Addiction. Prim psychiatry. 2009. Aug;16(8):33–9. doi: 10.1016/j.dsx.2020.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.06.008</ArticleId><ArticleId IdType="pmc">PMC3623011</ArticleId><ArticleId IdType="pubmed">26030747</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes on Drug Abuse (US). Common Comorbidities with Substance Use Disorders Research Report. 2020; Available from: https://www.ncbi.nlm.nih.gov/books/NBK571451/</Citation><ArticleIdList><ArticleId IdType="pubmed">34185444</ArticleId></ArticleIdList></Reference><Reference><Citation>Brady KT, Haynes LF, Hartwell KJ, Killeen TK. Substance use disorders and anxiety: A treatment challenge for social workers. Soc Work Public Health. 2013;28(3–4):407–23. doi: 10.1080/19371918.2013.774675</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19371918.2013.774675</ArticleId><ArticleId IdType="pmc">PMC3775646</ArticleId><ArticleId IdType="pubmed">23731428</ArticleId></ArticleIdList></Reference><Reference><Citation>Compton WM, Cottler LB, Jacobs JL, Ben-Abdallah A, Spitznagel EL. The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am J Psychiatry. 2003;160(5):890–5. doi: 10.1176/appi.ajp.160.5.890</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.160.5.890</ArticleId><ArticleId IdType="pubmed">12727692</ArticleId></ArticleIdList></Reference><Reference><Citation>Stratton SJ. COVID-19: Not a Simple Public Health Emergency. Prehosp Disaster Med [Internet]. 2020/03/13. 2020;35(2):119. Available from: https://www.cambridge.org/core/article/covid19-not-a-simple-public-health-emergency/2425C669F59CF3B5F07DA33F78DC20E8
</Citation><ArticleIdList><ArticleId IdType="pubmed">32167445</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaami S, Marinelli E, Varì MR. New Trends of Substance Abuse During COVID-19 Pandemic: An International Perspective [Internet]. Vol. 11, Frontiers in Psychiatry. 2020. Available from: https://www.frontiersin.org/articles/10.3389/fpsyt.2020.00700</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2020.00700</ArticleId><ArticleId IdType="pmc">PMC7378810</ArticleId><ArticleId IdType="pubmed">32765328</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashim JH, Adman MA, Hashim Z, Mohd Radi MF, Kwan SC. COVID-19 Epidemic in Malaysia: Epidemic Progression, Challenges, and Response [Internet]. Vol. 9, Frontiers in Public Health. 2021. Available from: https://www.frontiersin.org/articles/10.3389/fpubh.2021.560592</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.560592</ArticleId><ArticleId IdType="pmc">PMC8138565</ArticleId><ArticleId IdType="pubmed">34026696</ArticleId></ArticleIdList></Reference><Reference><Citation>Murali S.
Mental Health in Malaysia During The Movement Control Order (MCO) [Internet]. 2021. Available from: https://tehtalk.com/mental-health-in-malaysia-during-the-movement-control-order-mco/</Citation></Reference><Reference><Citation>Singh S, Roy D, Sinha K, Parveen S, Sharma G, Joshi G. Impact of COVID-19 and lockdown on mental health of children and adolescents: A narrative review with recommendations. Psychiatry Res [Internet]. 2020;293:113429. Available from: https://www.sciencedirect.com/science/article/pii/S016517812031725X
doi: 10.1007/s00787-021-01856-w

</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00787-021-01856-w</ArticleId><ArticleId IdType="pmc">PMC7444649</ArticleId><ArticleId IdType="pubmed">32882598</ArticleId></ArticleIdList></Reference><Reference><Citation>Gloster AT, Lamnisos D, Lubenko J, Presti G, Squatrito V, Constantinou M, et al.. Impact of COVID-19 pandemic on mental health: An international study. PLoS One [Internet]. 2021. Dec 31;15(12):e0244809. Available from: 10.1371/journal.pone.0244809</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0244809</ArticleId><ArticleId IdType="pmc">PMC7774914</ArticleId><ArticleId IdType="pubmed">33382859</ArticleId></ArticleIdList></Reference><Reference><Citation>Djuric O, Mancuso P, Zannini A, Nicolaci A, Massari M, Zerbini A, et al.. Are Individuals with Substance Use Disorders at Higher Risk of SARS-CoV-2 Infection? Population-Based Registry Study in Northern Italy. Eur Addict Res. 2021;27(4):263–7. doi: 10.1159/000515101</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000515101</ArticleId><ArticleId IdType="pmc">PMC8247799</ArticleId><ArticleId IdType="pubmed">33951659</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagisetty PA, Maust D, Heisler M, Bohnert A. Physical and Mental Health Comorbidities Associated With Primary Care Visits For Substance Use Disorders. Vol. 11, Journal of addiction medicine. United States; 2017. p. 161–2. doi: 10.1097/ADM.0000000000000280</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ADM.0000000000000280</ArticleId><ArticleId IdType="pmc">PMC5356485</ArticleId><ArticleId IdType="pubmed">28301371</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagisetty P, Klasa K, Bush C, Heisler M, Chopra V, Bohnert A. Primary care models for treating opioid use disorders: What actually works? A systematic review. PLoS One [Internet]. 2017. Oct 17;12(10):e0186315. Available from: 10.1371/journal.pone.0186315</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0186315</ArticleId><ArticleId IdType="pmc">PMC5645096</ArticleId><ArticleId IdType="pubmed">29040331</ArticleId></ArticleIdList></Reference><Reference><Citation>Peacock A, Leung J, Larney S, Colledge S, Hickman M, Rehm J, et al.. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addiction [Internet]. 2018. Oct 1;113(10):1905–26. Available from: 10.1111/add.14234</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/add.14234</ArticleId><ArticleId IdType="pubmed">29749059</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaggwa MM, Abaatyo J, Alol E, Muwanguzi M, Najjuka SM, Favina A, et al.. Substance use disorder among adolescents before and during the COVID-19 pandemic in Uganda: Retrospective findings from a psychiatric ward registry. PLoS One [Internet]. 2022. May 26;17(5):e0269044. Available from: 10.1371/journal.pone.0269044</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0269044</ArticleId><ArticleId IdType="pmc">PMC9135190</ArticleId><ArticleId IdType="pubmed">35617261</ArticleId></ArticleIdList></Reference><Reference><Citation>Avena NM, Simkus J, Lewandowski A, Gold MS, Potenza MN. Substance Use Disorders and Behavioral Addictions During the COVID-19 Pandemic and COVID-19-Related Restrictions [Internet]. Vol. 12, Frontiers in Psychiatry. 2021. Available from: https://www.frontiersin.org/articles/10.3389/fpsyt.2021.653674</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.653674</ArticleId><ArticleId IdType="pmc">PMC8085389</ArticleId><ArticleId IdType="pubmed">33935838</ArticleId></ArticleIdList></Reference><Reference><Citation>Ornell F, Schuch JB, Sordi AO, Kessler FHP. “Pandemic fear” and COVID-19: mental health burden and strategies. Vol. 42, Revista brasileira de psiquiatria (Sao Paulo, Brazil: 1999). Brazil; 2020. p. 232–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236170</ArticleId><ArticleId IdType="pubmed">32267343</ArticleId></ArticleIdList></Reference><Reference><Citation>Sureshchandra S, Raus A, Jankeel A, Ligh BJK, Walter NAR, Newman N, et al.. Dose-dependent effects of chronic alcohol drinking on peripheral immune responses. Sci Rep [Internet]. 2019;9(1):7847. Available from: 10.1038/s41598-019-44302-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-44302-3</ArticleId><ArticleId IdType="pmc">PMC6534547</ArticleId><ArticleId IdType="pubmed">31127176</ArticleId></ArticleIdList></Reference><Reference><Citation>Neta G, Brownson RC, Chambers DA. Opportunities for Epidemiologists in Implementation Science: A Primer. Am J Epidemiol [Internet]. 2018. May 1;187(5):899–910. Available from: 10.1093/aje/kwx323</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwx323</ArticleId><ArticleId IdType="pmc">PMC6279080</ArticleId><ArticleId IdType="pubmed">29036569</ArticleId></ArticleIdList></Reference><Reference><Citation>Yahaya AZ bin, Yee A, Sulaiman AH. The Pattern of Substance Use among People Who Use Drugs (PWUD) Receiving Treatment at University Malaya Medical Centre (UMMC) during the COVID-19 Pandemic and the Associated Factors. Healthc. 2022;10(8).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9332428</ArticleId><ArticleId IdType="pubmed">35893189</ArticleId></ArticleIdList></Reference><Reference><Citation>OECD. Coronavirus (COVID-19) From pandemic to recovery: Local employment and economic development. OECD Policy Responses to Coronavirus [Internet]. 2020;1–20. Available from: 10.1787/879d2913-en</Citation><ArticleIdList><ArticleId IdType="doi">10.1787/879d2913-en</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim I.
After backlash, Putrajaya now says breweries “not essential” and must stop operating immediately. Malay Mail [Internet]. 2021. 
Jun
1; Available from: https://www.malaymail.com/news/malaysia/2021/06/01/after-backlash-putrajaya-now-says-alcohol-factories-not-essential-and-must/1978779</Citation></Reference><Reference><Citation>Arya S, Ghosh A, Mishra S, Swami MK, Prasad S, Somani A, et al.. Impact of COVID-19 lockdown on substance availability, accessibility, pricing, and quality: A multicenter study from India. Indian J Psychiatry. 2022;64(5):466–72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9707667</ArticleId><ArticleId IdType="pubmed">36458079</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhoudian A, Razaghi E, Hooshyari Z, Noroozi A, Pilevari A, Mokri A, et al.. Barriers and Facilitators to Substance Use Disorder Treatment: An Overview of Systematic Reviews. Subst Abuse. 2022;16:11782218221118462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9434658</ArticleId><ArticleId IdType="pubmed">36062252</ArticleId></ArticleIdList></Reference><Reference><Citation>del Palacio-Gonzalez A, Thylstrup B, Houborg E. The impact of the COVID-19 lockdown on services for substance use in Denmark: Implications for meeting users’ needs and recommendations for the future. NAD Nord Stud Alcohol Drugs. 2022;39(2):175–89. doi: 10.1177/14550725211069229</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14550725211069229</ArticleId><ArticleId IdType="pmc">PMC9189563</ArticleId><ArticleId IdType="pubmed">35757093</ArticleId></ArticleIdList></Reference><Reference><Citation>Dannatt L, Ransing R, Calvey T, Scheibein F, Saad NA, Shirasaka T, et al.. The Impact of Stigma on Treatment Services for People With Substance Use Disorders During the COVID-19 Pandemic-Perspectives of NECPAM Members. Front psychiatry. 2021;12:634515. doi: 10.3389/fpsyt.2021.634515</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.634515</ArticleId><ArticleId IdType="pmc">PMC7982835</ArticleId><ArticleId IdType="pubmed">33762979</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh D, Chawarski MC, Schottenfeld R, Vicknasingam B. Substance Abuse and the HIV Situation in Malaysia. J food drug Anal. 2013. Dec;21(4):S46–51. doi: 10.1016/j.jfda.2013.09.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfda.2013.09.033</ArticleId><ArticleId IdType="pmc">PMC4179250</ArticleId><ArticleId IdType="pubmed">25278737</ArticleId></ArticleIdList></Reference><Reference><Citation>Du P, Liu X, Zhong G, Zhou Z, Thomes MW, Lee CW, et al.. Monitoring consumption of common illicit drugs in kuala lumpur, malaysia, by wastewater-cased epidemiology. Int J Environ Res Public Health. 2020;17(3):1–11. doi: 10.3390/ijerph17030889</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17030889</ArticleId><ArticleId IdType="pmc">PMC7036889</ArticleId><ArticleId IdType="pubmed">32023897</ArticleId></ArticleIdList></Reference><Reference><Citation>AADK. Trend Statistik Penagih Dadah Dikesan AADK Mengikut Jenis Dadah, 2016–2020 [Internet]. [cited 2023 Mar 24]. Available from: https://www.adk.gov.my/trend-statistik-penagih-dadah-dikesan-aadk-mengikut-jenis-dadah-2016-2020/</Citation></Reference><Reference><Citation>Favrod-Coune T, Broers B. The Health Effect of Psychostimulants: A Literature Review. Pharmaceuticals (Basel). 2010. Jul;3(7):2333–61. doi: 10.3390/ph3072333</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph3072333</ArticleId><ArticleId IdType="pmc">PMC4036656</ArticleId><ArticleId IdType="pubmed">27713356</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen CJ, Wickersham JA, Altice FL, Kamarulzaman A, Khoshnood K, Gibson BA, et al.. Prevalence and Correlates of Active Amphetamine-Type Stimulant Use Among Female Sex Workers in Malaysia. Front Psychiatry. 2022;13(June):1–7. doi: 10.3389/fpsyt.2022.879479</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.879479</ArticleId><ArticleId IdType="pmc">PMC9237260</ArticleId><ArticleId IdType="pubmed">35774093</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction. 2009. Jul;104(7):1085–99. doi: 10.1111/j.1360-0443.2009.02564.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1360-0443.2009.02564.x</ArticleId><ArticleId IdType="pubmed">19426289</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail I, Wahab S, Sidi H, Das S, Lin LJ, Razali R. Kratom and Future Treatment for the Opioid Addiction and Chronic Pain: Periculo Beneficium? Curr Drug Targets. 2017;20(2):166–72.</Citation><ArticleIdList><ArticleId IdType="pubmed">28443503</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh D, Yeou Chear NJ, Narayanan S, Leon F, Sharma A, McCurdy CR, et al.. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users. J Ethnopharmacol [Internet]. 2020;249(December 2019):112462. Available from: 10.1016/j.jep.2019.112462</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2019.112462</ArticleId><ArticleId IdType="pubmed">31816368</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Sharma A, León F, Avery B, Kjelgren R, McCurdy CR, et al.. Plant growth and phytoactive alkaloid synthesis in kratom [Mitragyna speciosa (Korth.)] in response to varying radiance. PLoS One. 2022;17(4):e0259326. doi: 10.1371/journal.pone.0259326</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0259326</ArticleId><ArticleId IdType="pmc">PMC9041851</ArticleId><ArticleId IdType="pubmed">35472200</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavakoli HR, Buchholz AC, Kabir IK, Deb A, Gayk JN. Expanding Substance Abuse Market. 2016;(November):32–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6373705</ArticleId><ArticleId IdType="pubmed">30766148</ArticleId></ArticleIdList></Reference><Reference><Citation>Kratom in Malaysia: History, usage, and legality [Internet]. 2022 [cited 2023 Jul 17]. Available from: https://www.borneohale.com/kratom-in-malaysia-history-use-health-cases-and-legality/</Citation></Reference><Reference><Citation>Saref A, Suraya S, Singh D, Grundmann O, Narayanan S, Swogger MT, et al.. Self-reported prevalence and severity of opioid and kratom (Mitragyna speciosa korth.) side effects. J Ethnopharmacol [Internet]. 2019;238(February):111876. Available from: 10.1016/j.jep.2019.111876</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2019.111876</ArticleId><ArticleId IdType="pubmed">31014959</ArticleId></ArticleIdList></Reference><Reference><Citation>Diep J, Chin DT, Gupta S, Syed F, Xiong M, Cheng J. Kratom, an Emerging Drug of Abuse: A Case Report of Overdose and Management of Withdrawal. A&amp;A Pract. 2018;10(8):192–4.</Citation><ArticleIdList><ArticleId IdType="pubmed">29652682</ArticleId></ArticleIdList></Reference><Reference><Citation>Center for Behavioral Health Statistics and Quality. 2016 National Survey on Drug Use and Health: Detailed Tables [Internet]. Substance Abuse and Mental Health Services Administration, Rockville, MD. 2017 [cited 2023 Mar 15]. Available from: https://www.samhsa.gov/data/sites/default/files/NSDUH-DetTabs-2016/NSDUH-DetTabs-2016.pdf</Citation></Reference><Reference><Citation>Devoto A, Himelein-Wachowiak M, Liu T, Curtis B. Women’s Substance Use and Mental Health During the COVID-19 Pandemic. Womens Health Issues. 2022;32(3):235–40. doi: 10.1016/j.whi.2022.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.whi.2022.01.004</ArticleId><ArticleId IdType="pmc">PMC8776461</ArticleId><ArticleId IdType="pubmed">35246351</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulis S, Hodge DR, Ayers SL, Brown EF, Marsiglia FF. Spirituality and Religion: Intertwined Protective Factors for Substance Use among Urban American Indian Youth. Am J Drug Alcohol Abuse [Internet]. 2012. Sep 1;38(5):444–9. Available from: 10.3109/00952990.2012.670338</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00952990.2012.670338</ArticleId><ArticleId IdType="pmc">PMC3431460</ArticleId><ArticleId IdType="pubmed">22554065</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Torre-Luque A, Ozeylem F, Essau CA. Prevalence of addictive behaviours among adolescents from 73 low-and middle-income countries. Addict Behav Reports [Internet]. 2021;14:100387. Available from: 10.1016/j.abrep.2021.100387</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abrep.2021.100387</ArticleId><ArticleId IdType="pmc">PMC8664882</ArticleId><ArticleId IdType="pubmed">34938845</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge KA, Skinner AT, Godwin J, Bai Y, Lansford JE, Copeland WE, et al.. Impact of the COVID-19 pandemic on substance use among adults without children, parents, and adolescents. Addict Behav Reports [Internet]. 2021;14:100388. Available from: 10.1016/j.abrep.2021.100388</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abrep.2021.100388</ArticleId><ArticleId IdType="pmc">PMC8664966</ArticleId><ArticleId IdType="pubmed">34938846</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundahl LH. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company ‘ s public news and information. 2020;(January).</Citation></Reference><Reference><Citation>Gu S, He Z, Sun L, Jiang Y, Xu M, Feng G, et al.. Effects of Coronavirus-19 Induced Loneliness on Mental Health: Sleep Quality and Intolerance for Uncertainty as Mediators. Front psychiatry. 2021;12:738003. doi: 10.3389/fpsyt.2021.738003</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.738003</ArticleId><ArticleId IdType="pmc">PMC8490824</ArticleId><ArticleId IdType="pubmed">34621198</ArticleId></ArticleIdList></Reference><Reference><Citation>Horigian VE, Schmidt RD, Feaster DJ. Loneliness, Mental Health, and Substance Use among US Young Adults during COVID-19. J Psychoactive Drugs. 2021;53(1):1–9. doi: 10.1080/02791072.2020.1836435</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02791072.2020.1836435</ArticleId><ArticleId IdType="pubmed">33111650</ArticleId></ArticleIdList></Reference><Reference><Citation>Na L, Yang L, Mezo PG, Liu R. Age disparities in mental health during the COVID19 pandemic: The roles of resilience and coping. Soc Sci Med [Internet]. 2022;305(January):115031. Available from: 10.1016/j.socscimed.2022.115031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2022.115031</ArticleId><ArticleId IdType="pmc">PMC9100296</ArticleId><ArticleId IdType="pubmed">35649300</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, et al.. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open. 2020;3(3):1–12. doi: 10.1001/jamanetworkopen.2020.3976</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.3976</ArticleId><ArticleId IdType="pmc">PMC7090843</ArticleId><ArticleId IdType="pubmed">32202646</ArticleId></ArticleIdList></Reference><Reference><Citation>Lear-Claveras A, Clavería A, Couso-Viana S, Nabbe P, Oliván-Blázquez B. Analysis of Drug and Health Resource Use Before and After COVID-19 Lockdown in a Population Undergoing Treatment for Depression or Anxiety. Front Psychol. 2022;13(April):1–8. doi: 10.3389/fpsyg.2022.861643</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2022.861643</ArticleId><ArticleId IdType="pmc">PMC9037328</ArticleId><ArticleId IdType="pubmed">35478736</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedermann CJ, Barbieri V, Plagg B, Marino P, Piccoliori G, Engl A. Fortifying the Foundations: A Comprehensive Approach to Enhancing Mental Health Support in Educational Policies Amidst Crises. Healthc (Basel, Switzerland). 2023. May;11(10).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10217808</ArticleId><ArticleId IdType="pubmed">37239709</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidi H. The Psychological Sequelae during Mental Health and COVID-19 Pandemic: Learning from the Past for Today’s Coping Styles. Med Health. 2020;15(1):1–4.</Citation></Reference><Reference><Citation>Murphy L, Markey K, O’ Donnell C, Moloney M, Doody O. The impact of the COVID-19 pandemic and its related restrictions on people with pre-existent mental health conditions: A scoping review. Arch Psychiatr Nurs. 2021. Aug;35(4):375–94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9759111</ArticleId><ArticleId IdType="pubmed">34176579</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>